Combined E-cadherin, α-catenin, and β-catenin expression is a favorable prognostic factor in endometrial carcinoma

International Journal of Gynecological Cancer

Volumn 16, Issue 3, 2006, Pages 1379-1385

  Scholten, A N ^a   Aliredjo, R ^a   Creutzberg, C L ^a   Smit, V T H B M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Catenins; E cadherin; Endometrial carcinoma; Histologic grade; Prognostic factors

Indexed keywords

ALPHA CATENIN; BETA CATENIN; UVOMORULIN;

ARTICLE; CANCER GRADING; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDOMETRIUM CARCINOMA; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

ALPHA CATENIN; BETA CATENIN; CADHERINS; CARCINOMA, ENDOMETRIOID; ENDOMETRIAL NEOPLASMS; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM INVASIVENESS; PROGNOSIS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 33745103655     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2006.00406.x     Document Type: Article

References (23)

1. Nollet F Kools P van Roy F. Phylogenetic analysis of the cadherin superfamily allows identification of six major subfamilies besides several solitary members. J Mol Biol 2000 299 : 551 72.
2. Van Aken E De Wever O Correia da Rocha AS Mareel M. Defective E-cadherin/catenin complexes in human cancer. Virchows Arch 2001 439 : 725 51.
3. Frixen UH Behrens J Sachs M et al. E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 1991 113 : 173 85.
4. Umbas R Schalken JA Aalders TW Carter BS Karthaus HF Schaafsma HE et al. Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer. Cancer Res 1992 52 : 5104 9.
5. Sakuragi N Nishiya M Ikeda K et al. Decreased E-cadherin expression in endometrial carcinoma is associated with tumor dedifferentiation and deep myometrial invasion. Gynecol Oncol 1994 53 : 183 9.
6. Leblanc M Poncelet C Soriano D et al. Alteration of CD44 and cadherins expression: possible association with augmented aggressiveness and invasiveness of endometrial carcinoma. Virchows Arch 2001 438 : 78 85.
7. Holcomb K Delatorre R Pedemonte B McLeod C Anderson L Chambers J. E-cadherin expression in endometrioid, papillary serous, and clear cell carcinoma of the endometrium. Obstet Gynecol 2002 100 : 1290 5.
8. Scholten AN Creutzberg CL Noordijk EM Smit VT. Long-term outcome in endometrial carcinoma favors a two - instead of a three-tiered grading system. Int J Radiat Oncol Biol Phys 2002 52 : 1067 74.
9. Shepherd JH. Revised FIGO staging for gynaecological cancer. Br J Obstet Gynaecol 1989 96 : 889 92.
10. Lax SF Kurman RJ Pizer ES Wu L Ronnett BM. A binary architectural grading system for uterine endometrial endometrioid carcinoma has superior reproducibility compared with FIGO grading and identifies subsets of advance-stage tumors with favorable and unfavorable prognosis. Am J Surg Pathol 2000 24 : 1201 8.
11. Hazelbag HM van den Broek LJ van Dorst EB Offerhaus GJ Fleuren GJ Hogendoorn PC. Immunostaining of chain-specific keratins on formalin-fixed, paraffin-embedded tissues: a comparison of various antigen retrieval systems using microwave heating and proteolytic pre-treatments. J Histochem Cytochem 1995 43 : 429 37.
12. Moreno-Bueno G Hardisson D Sarrio D et al. Abnormalities of E- and P-cadherin and catenin (beta-, gamma-catenin, and p120 ctn) expression in endometrial cancer and endometrial atypical hyperplasia. J Pathol 2003 199 : 471 8.
13. Creutzberg CL van Putten WL Koper PC et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma. Lancet 2000 355 : 1404 11.
14. Parker C Rampaul RS Pinder SE et al. E-cadherin as a prognostic indicator in primary breast cancer. Br J Cancer 2001 85 : 1958 63.
15. Gamallo C Moreno-Bueno G Sarrio D Calero F Hardisson D Palacios J. The prognostic significance of P-cadherin in infiltrating ductal breast carcinoma. Mod Pathol 2001 14 : 650 4.
16. Elzagheid A Kuopio T Ilmen M Collan Y. Prognostication of invasive ductal breast cancer by quantification of E-cadherin immunostaining: the methodology and clinical relevance. Histopathology 2002 41 : 127 33.
17. Moll R Mitze M Frixen UH Birchmeier W. Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas. Am J Pathol 1993 143 : 1731 42.
18. Goldstein NS. Does the level of E-cadherin expression correlate with the primary breast carcinoma infiltration pattern and type of systemic metastases?. Am J Clin Pathol 2002 118 : 425 34.
19. Huiping C Kristjansdottir S Jonasson JG Magnusson J Egilsson V Ingvarsson S. Alterations of E-cadherin and beta-catenin in gastric cancer. BMC Cancer 2001 1 : 16.
20. Demopoulos RI Mesia AF Mittal K Vamvakas E. Immunohistochemical comparison of uterine papillary serous and papillary endometrioid carcinoma: clues to pathogenesis. Int J Gynecol Pathol 1999 18 : 233 7.
21. Schlosshauer PW Ellenson LH Soslow RA. Beta-catenin and E-cadherin expression patterns in high-grade endometrial carcinoma are associated with histological subtype. Mod Pathol 2002 15 : 1032 7.
22. Sherman ME Bur ME Kurman RJ. p53 in endometrial cancer and its putative precursors: evidence for diverse pathways of tumorigenesis. Hum Pathol 1995 26 : 1268 74.
23. Vos CB Cleton-Jansen AM Berx G et al. E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis. Br J Cancer 1997 76 : 1131 3.